AADI News and Press, Aadi Bioscience Inc. From 05/10/23

2023-05-10 11:33:02 ET Aadi Bioscience, Inc. (AADI) Q1 2023 Earnings Conference Call May 10, 2023, 08:30 AM ET Company Participants Marcy Graham - Senior Vice President of Investor Relations and Corporate Communications Neil Desai - Founder and Executive Chairman ...

2023-05-10 08:32:03 ET Aadi Bioscience press release ( NASDAQ: AADI ): Q1 GAAP EPS of -$0.57 beats by $0.03 . Revenue of $5.9M (+155.4% Y/Y) beats by $0.42M . Cash, cash equivalents and short-term investments as of March 31, 2023 were $151.2 million as compared...

Aadi Bioscience Announces Financial Results and Operational Update for the First Quarter 2023 and Provides Update on PRECISION 1 Tumor Agnostic Trial PR Newswire Total 1Q 2023 revenue on FYARRO® sales of $5.9 million PRECISION 1 tumor agnostic trial enrolling ...

2023-05-09 13:16:10 ET Aadi Bioscience ( NASDAQ: AADI ) is scheduled to announce Q1 earnings results on Wednesday, May 10th, before market open. The consensus EPS Estimate is -$0.62 (+6.1% Y/Y) and the consensus Revenue Estimate is $5.48M (+137.2% Y/Y). Over the last 3...

Aadi Bioscience to Report First Quarter 2023 Results and Operational Update PR Newswire Company to Host Conference Call and Webcast on Wednesday, May 10, 2023 LOS ANGELES , May 3, 2023 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial...

Aadi Bioscience Announces Multiple Presentations on nab-Sirolimus at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting PR Newswire LOS ANGELES , April 26, 2023 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmace...

Aadi Bioscience to Present Multiple Posters on nab-Sirolimus at the 2023 American Association for Cancer Research (AACR) Annual Meeting PR Newswire LOS ANGELES , April 14, 2023 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceut...

Aadi Bioscience to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2023 PR Newswire LOS ANGELES , April 6, 2023 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focus...

2023-03-28 11:36:06 ET Aadi Bioscience, Inc. (AADI) Q4 2022 Earnings Conference Call March 28, 2023, 08:30 AM ET Company Participants Marcy Graham - Senior Vice President of Investor Relations and Corporate Communications Neil Desai - Founder and Executive Chairman ...

2023-03-28 11:34:48 ET The following slide deck was published by Aadi Bioscience, Inc. in conjunction with their 2022 Q4 earnings call. For further details see: Aadi Bioscience, Inc. 2022 Q4 - Results - Earnings Call Presentation